🇺🇸·Jun 12Industry
Why Do I Pheel This Way? Episode 2 Explores Social Life, Support and Self-Advocacy for Teens with Phenylketonuria
Publisher
B
BioMarin Pharmaceutical
USA
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- BioMarin Pharmaceutical
- Region
- USA
- Scope
- Industry
- Published
- June 12, 2026
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on biomarin.com
Leave the platform to read the original full article on the publisher site.
Source: BioMarin Pharmaceutical
Scope: Industry
Related coverage
More related coverage
Bambusa Therapeutics/5h ago
Bambusa Therapeutics Reports Potentially Transformative Preliminary Proof-of-Concept Results for BBT001 in Atopic Dermatitis, Reinforcing Its Best-in-Disease Potential
Otsuka Pharmaceutical/13h ago
Otsuka Launches POCARI SWEAT ION WATER Powder Stick Packet to Make 500mlEasy Water and Ion Replenishment for Day-to-Day Situations: Ideal for Use with Reusable Bottles
Otsuka Holdings RSS/15h ago
Otsuka Receives FDA Approval for First-in-Class SIMTRIYO (centanafadine) for the Treatment of Attention-Deficit Hyperactivity Disorder (ADHD) in Adults and Pediatric Patients Aged 6 Years and Older
Natco Pharma/15h ago